Team
Maha Ayyoub
T2i :
Anti-tumour immunity and immunotherapy
The specificities
of our research axis
Tumour antigen-specific T cells
T cell depletion
Immune checkpoint inhibitor immunotherapy
Anti-cancer vaccines
Clinical trials
Pre-clinical orthotopic models
Genomics
Trancriptomics
Research
projects
Immune complexity of epithelial cancers
Pr Alejandra Martinez et Dr Anna Salvioni
Impact of tumour immune microenvironments on the response to immunotherapies
Christel Devaud
Targeting autophagy in cancer immunotherapy
Sylvie Giuriato
Setting up clinical trials and immune monitoring of patients treated with immunotherapy.
Clara-Maria Scarlata
Role of tumour ag-specific T cells in the clinical response to immunotherapy
Pr Maha Ayyoub
THE TEAM’S
FOCUS
Discover
Understand
Participate
Live Feed
#Postdoctoral fellow at the #Cancer Research Center, Toulouse, France on the impact of combining #TNF blockade and #immunotherapy on #immune responses and #melanoma liver metastases in #mice.
2 year contract from Nov 1, 2023
Contact bruno.segui@inserm.fr before October 15, 2023.
Scientific production
PUBLICATIONS 2024
PUBLICATIONS 2023
PUBLICATIONS 2022
PUBLICATIONS 2021
PUBLICATIONS 2020
PUBLICATIONS 2019
LES MEMBRES DE L’ÉQUIPE
Partnerships & Funding
Centre de Recherches en Cancérologie de Toulouse (Oncopole)
Toulouse – FR
CRCT-Oncopole Follow 1,220 1,117
Compte officiel du Centre de Recherches en Cancérologie de Toulouse
Castelnau-Montratier célèbre la lutte contre le cancer. Jeudi 24 août 2023 conférence avec Frédéric Chibon responsable de l'équipe @OncoSarc du @crctoncopole accompagné de Gwenaël Ferron et Martin Gauthier oncologue @IUCTOncopole
Découvrir l'équipe
➡️https://www.crct-inserm.fr/oncosarc/
Nous contacter
05 82 74 15 75
Envie de rejoindre
L’équipe du CRCT ?